Predictors of pre-eclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

Am J Obstet Gynecol. 1998 Oct;179(4):946-51. doi: 10.1016/s0002-9378(98)70194-2.

Abstract

Objective: We assessed several variables as predictors for pre-eclampsia risk in a group of women at high risk.

Study design: We studied 2503 women with either diabetes mellitus, chronic hypertension, multifetal gestation, or pre-eclampsia in a previous pregnancy who participated in a multicenter study comparing aspirin and placebo in preventing pre-eclampsia. We evaluated multiple variables for predicting pre-eclampsia risk with use of univariate and multivariable analysis.

Results: Parity and mean arterial pressure at randomization were most predictive of pre-eclampsia risk. The risk was 8% with a mean arterial pressure at enrollment of <75 mm Hg versus 27% with a mean arterial pressure >85 mm Hg (relative risk and 95% confidence interval 3.3 [2.4 to 4.4]). The risk of pre-eclampsia was 26% in nulliparous patients versus 17% in parous subjects (relative risk and 95% confidence interval 1.5 [1.3-1.8]).

Conclusions: The finding that second-trimester mean arterial pressure affects pre-eclampsia risk suggests that the pathophysiologic process of preeclampsia is initiated before that time.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aspirin / therapeutic use
  • Blood Pressure
  • Female
  • Gestational Age
  • Humans
  • Hypertension / complications
  • Parity
  • Placebos
  • Pre-Eclampsia / etiology*
  • Pre-Eclampsia / prevention & control
  • Pregnancy
  • Pregnancy in Diabetics / complications
  • Pregnancy, Multiple
  • Risk Factors

Substances

  • Placebos
  • Aspirin